Addus HomeCare Co. (NASDAQ:ADUS) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Addus HomeCare Co. (NASDAQ:ADUSGet Free Report) have been given a consensus recommendation of “Moderate Buy” by the eight analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $113.43.

Several equities research analysts have commented on the stock. Barclays downgraded shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective on the stock. in a report on Tuesday, April 23rd. Royal Bank of Canada reiterated an “outperform” rating and set a $102.00 price target on shares of Addus HomeCare in a research report on Thursday, February 29th. TD Cowen upped their price target on shares of Addus HomeCare from $119.00 to $128.00 and gave the stock a “buy” rating in a report on Tuesday. StockNews.com raised Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Thursday, June 6th. Finally, Stephens lifted their target price on shares of Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a research report on Friday, May 31st.

Get Our Latest Report on Addus HomeCare

Insider Activity

In other news, EVP Roberton James Stevenson sold 217 shares of the business’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $116.13, for a total transaction of $25,200.21. Following the completion of the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 4.60% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. boosted its position in Addus HomeCare by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock worth $131,910,000 after purchasing an additional 19,027 shares in the last quarter. Wellington Management Group LLP raised its stake in Addus HomeCare by 1.2% in the 4th quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock valued at $74,135,000 after purchasing an additional 9,548 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Addus HomeCare by 0.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 698,498 shares of the company’s stock valued at $64,857,000 after purchasing an additional 5,654 shares during the last quarter. TimesSquare Capital Management LLC increased its stake in shares of Addus HomeCare by 9.8% in the 1st quarter. TimesSquare Capital Management LLC now owns 289,998 shares of the company’s stock worth $29,968,000 after acquiring an additional 25,910 shares during the last quarter. Finally, Summit Creek Advisors LLC increased its stake in shares of Addus HomeCare by 0.7% in the 1st quarter. Summit Creek Advisors LLC now owns 268,224 shares of the company’s stock worth $27,718,000 after acquiring an additional 1,739 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $119.30 on Friday. The company has a market cap of $1.95 billion, a P/E ratio of 29.60, a PEG ratio of 2.25 and a beta of 1.02. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. The business has a 50-day moving average price of $106.84 and a two-hundred day moving average price of $98.67. Addus HomeCare has a 1-year low of $78.35 and a 1-year high of $119.98.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its quarterly earnings data on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The firm had revenue of $280.70 million during the quarter, compared to analysts’ expectations of $279.49 million. During the same quarter last year, the firm posted $0.84 earnings per share. The company’s revenue for the quarter was up 11.6% compared to the same quarter last year. As a group, analysts anticipate that Addus HomeCare will post 4.36 EPS for the current year.

About Addus HomeCare

(Get Free Report

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.